Last reviewed · How we verify
Conventional drugs — Competitive Intelligence Brief
phase 3
Conventional drug
Cardiovascular
Small molecule
Live · refreshed every 30 min
Target snapshot
Conventional drugs (Conventional drugs) — University of Science and Technology, Yemen. This drug works by inhibiting the action of a specific enzyme.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Conventional drugs TARGET | Conventional drugs | University of Science and Technology, Yemen | phase 3 | Conventional drug |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Conventional drug class)
- University of Science and Technology, Yemen · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Conventional drugs CI watch — RSS
- Conventional drugs CI watch — Atom
- Conventional drugs CI watch — JSON
- Conventional drugs alone — RSS
- Whole Conventional drug class — RSS
Cite this brief
Drug Landscape (2026). Conventional drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/conventional-drugs. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing